Where the guideline stands	Insufficient evidence to recommend either way
Availability	Prescription
How long before you judge it	Variable
Pregnancy	Sometimes used when a macrolide is needed in pregnancy; a clinician decision.
Sources behind this page	8, every one linked at the bottom

Azithromycin for Acne at a glance. Recommendation strength and evidence certainty are separate axes under GRADE.

What it is

Azithromycin is a macrolide antibiotic, Replace ‘chest, sinus, skin and urinary infections’ with ‘chest, sinus, ear, skin and certain sexually transmitted infections’.. Acne is not one of its approved indications, so every acne prescription is off-label. In acne it works the way other oral antibiotics do: it suppresses Cutibacterium acnes in the follicle and damps down the inflammation that turns a blocked pore into a red papule or pustule. Its distinguishing feature is pharmacological. Azithromycin concentrates in tissue and has a long half-life, so it can be given in pulses (a single weekly dose, or a few days at intervals) rather than every day.

What the evidence actually shows

The head-to-head evidence is better than azithromycin’s guideline position suggests. A 2018 meta-analysis in Annals of Dermatology (Kim et al.) pooled six randomised controlled trials and 906 patients with moderate to severe acne and found no statistically significant difference between azithromycin pulse therapy and daily doxycycline in remaining lesion counts (p=0.27), patient self-assessment (p=0.67) or investigator assessment (p=0.32). Severe adverse events causing discontinuation were more frequent in the doxycycline arms. A 2026 open-label randomised trial in Oman (163 participants, azithromycin 500 mg weekly versus doxycycline 100 mg daily for 12 weeks) reached the same conclusion: comparable clearing and comparable quality-of-life gains. So why does the guideline demote it? Recommendation 2.4 is conditional and rests on low-certainty evidence, and it is framed as a preference between two drugs rather than a verdict on azithromycin alone. Azithromycin never gets a recommendation of its own: besides appearing in 2.4 as the comparator that lost, it is covered by the guideline’s systemic-antibiotics insufficient-evidence statement, which is a finding of insufficient evidence, not a recommendation against it. The trials behind it are small, largely open-label and use pulse regimens that differ from study to study, which is what low certainty describes. Doxycycline, by contrast, carries a strong recommendation on moderate-certainty evidence. Stewardship weighs against azithromycin too. A 2024 systematic review and meta-analysis of Cutibacterium acnes isolates (Beig et al., Journal of Global Antimicrobial Resistance) found pooled resistance of 36.6% to erythromycin and 14.9% to azithromycin, against 6.2% for tetracycline, 7.9% for doxycycline and 2.5% for minocycline. Macrolide resistance in the organism is already the widest of the classes used in acne.

How it is actually used

This is not a drug to seek out by name. Where it is used, it is chosen by a prescriber who has a specific reason to avoid tetracyclines: intolerance, allergy, pregnancy, or another situation where a tetracycline is unsuitable. Dosing is not standardised: trials have used weekly or intermittent pulse regimens that differ from one study to the next, which is part of why the evidence is rated low certainty. The trials that exist assessed response at 12 weeks, so that is a reasonable horizon before judging it. Two of the guideline’s good practice statements apply to any oral antibiotic for acne: keep the course as short as possible, and pair it with benzoyl peroxide and other topical therapy. The topical work is what holds the result once the antibiotic stops.

Safety and who should avoid it

The warning that matters most is cardiac. In March 2013 the FDA warned that azithromycin can prolong the QT interval and cause a potentially fatal arrhythmia, with risk concentrated in people who already have QT prolongation, low potassium or magnesium, a slow heart rate, existing cardiac disease, or who take certain antiarrhythmic drugs. The prescribing information also carries warnings for hepatotoxicity, Clostridioides difficile diarrhoea, and rare severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis. Everyday effects are mostly gastrointestinal. On pregnancy, the label states that decades of published and postmarketing data have not identified drug-associated risks of major birth defects or miscarriage, but acne is an off-label use, and that is a clinician’s judgement, not a green light.

Commonly repeated: weekly pulse dosing makes azithromycin the resistance-friendly oral antibiotic for acne. What the evidence actually shows: the opposite direction. A 2024 systematic review and meta-analysis of Cutibacterium acnes isolates found pooled resistance of 36.6% to erythromycin and 14.9% to azithromycin, against 6.2% for tetracycline and 2.5% for minocycline. Macrolide resistance is the most widespread of the classes used in acne, and the 2024 AAD guideline conditionally prefers doxycycline over azithromycin.

Sources

Keep reading

See where this sits against every other acne treatment on the acne treatment evidence map, or check how it combines with another ingredient in the ingredient combination checker. For the guideline’s own wording on this, see the 2024 AAD guideline, recommendation by recommendation.

Not medical advice

This page reports what the published evidence says about a treatment. It is not a treatment plan and it cannot account for your skin, your other medications or your medical history. Nothing here has been reviewed by a clinician; see our editorial policy for what that means. Talk to a clinician before starting or stopping any prescription treatment.

Research, not medical advice. Every clinical claim above links to the guideline, systematic review, trial or drug label it came from, so you can check it yourself rather than take my word for it. It was researched and drafted with AI assistance by a non-clinician, and no dermatologist has reviewed it: this site does the reading, it doesn’t practise medicine. It can’t account for your circumstances either, so talk to a dermatologist or doctor about your own skin, especially before starting or stopping a prescription treatment.

Azithromycin for Acne: When Is It Used?